AHA: Rivaroxaban Drops Pro-Coagulation Factor in HF Patients (CME/CE)
ORLANDO (MedPage Today) Biomarkers of hypercoagulability an ominous sign in patients with heart failure appear to be reduced by treatment with the oral, direct Factor Xa inhibitor rivaroxaban, a researcher said at the AHA meeting here.
source : www.medpagetoday.com
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
CreditReport.com
Get your credit report and score in just seconds!
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
CreditReport.com
Get your credit report and score in just seconds!
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Related News:
- ACC: STEMI Patients Helped by Aspirating the Clot
- Depression: Antidepressants beneficial in physically ill patients
- The Human Brain: Exploring Status Quo Bias
- Treating Back Pain In Blood Marrow Cancer Patients
- License Agreement To Develop Treatments For Neurological Disease Announced By Brain Science Institute
- FDA Panel Recommends Approval With Conditions Of Medtronic Deep Brain Stimulation Therapy For Patients With Refractory Epilepsy
- Researchers Find Younger, More Diverse Patients Having Total Knee Replacements
- Knee Replacement In Elderly Patients Shown To Improve Balance
- AAOS: Cementless Hips Better for Younger Patients
- New Hope To Vitiligo Patients Offered By Skin Transplant
Details :
Submited at Monday, November 16th, 2009 at 1:00 am on Cardiology by Alina
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...